Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).
Bell CF, Bobbili P, Desai R, Gibbons DC, Drysdale M, DerSarkissian M, Patel V, Birch HJ, Lloyd EJ, Zhang A, Duh MS; N3C consortium. Bell CF, et al. Among authors: dersarkissian m. Clin Drug Investig. 2024 Mar;44(3):183-198. doi: 10.1007/s40261-024-01344-4. Epub 2024 Feb 20. Clin Drug Investig. 2024. PMID: 38379107 Free PMC article.
Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study.
Wang PF, Yee CW, Gorsh B, Zichlin ML, Paka P, Bhak RH, Boytsov N, Khanal A, Noman A, DerSarkissian M, Ferrante S, Duh MS. Wang PF, et al. Among authors: dersarkissian m. Leuk Lymphoma. 2023 Feb;64(2):398-406. doi: 10.1080/10428194.2022.2140284. Epub 2022 Nov 21. Leuk Lymphoma. 2023. PMID: 36408998
A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA.
Bell CF, Huang SP, Yu LH, DerSarkissian M, Germain G, Concoff AL, Averell CM, Rubin B, Gu YM, Duh MS, Wallace DJ. Bell CF, et al. Among authors: dersarkissian m. Rheumatol Ther. 2023 Feb;10(1):261-274. doi: 10.1007/s40744-022-00509-x. Epub 2022 Dec 5. Rheumatol Ther. 2023. PMID: 36471198 Free PMC article.
Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL).
Patel H, Wahlstrom SK, DerSarkissian M, Kunzweiler C, Castriota F, Chang R, Gu Y, Guo H, Duh MS, Ryan KJ. Patel H, et al. Among authors: dersarkissian m. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(6):651-658. doi: 10.1080/14737167.2023.2200167. Epub 2023 Apr 11. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37021518
76 results